{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T15:57:00Z","timestamp":1770220620943,"version":"3.49.0"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Veterinary Cardiology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.jvc.2015.10.006","type":"journal-article","created":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T22:15:53Z","timestamp":1452896153000},"page":"S202-S214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"S1","title":["Cardiogenic embolism in the cat"],"prefix":"10.1016","volume":"17","author":[{"given":"Daniel F.","family":"Hogan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin M.","family":"Brainard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvc.2015.10.006_bib1","series-title":"Current veterinary therapy IX","first-page":"380","article-title":"Feline myocardial diseases","author":"Harpster","year":"1986"},{"key":"10.1016\/j.jvc.2015.10.006_bib2","series-title":"Kirk's current veterinary therapy XII","first-page":"863","article-title":"Restrictive cardiomyopathy","author":"Bonagura","year":"1995"},{"key":"10.1016\/j.jvc.2015.10.006_bib3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.5326\/15473317-31-6-492","article-title":"A retrospective study of 100 cases of feline distal aortic thromboembolism: 1977\u20131993","volume":"31","author":"Laste","year":"1995","journal-title":"J Am Anim Hosp Assoc"},{"key":"10.1016\/j.jvc.2015.10.006_bib4","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2460\/javma.1992.201.04.613","article-title":"Risk factors, clinical signs, and survival in cats with a clinical diagnosis of idiopathic hypertrophic cardiomyopathy: 74 cases (1985\u20131989)","volume":"201","author":"Atkins","year":"1992","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.jvc.2015.10.006_bib5","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1939-1676.2001.tb01598.x","article-title":"Natural history of hypertrophic cardiomyopathy and aortic thromboembolism in a family of domestic shorthair cats","volume":"15","author":"Baty","year":"2001","journal-title":"J Vet Int Med"},{"key":"10.1016\/j.jvc.2015.10.006_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1476-4431.2000.tb00010.x","article-title":"Retrospective study of streptokinase administration in 46 cats with arterial thromboembolism","volume":"10","author":"Moore","year":"2000","journal-title":"J Vet Emerg Crit Care"},{"key":"10.1016\/j.jvc.2015.10.006_bib7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2460\/javma.2002.220.202","article-title":"Population and survival characteristics of cats with hypertrophic cardiomyopathy: 260 cases (1990\u20131999)","volume":"220","author":"Rush","year":"2002","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.jvc.2015.10.006_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1939-1676.1993.tb03184.x","article-title":"Heterogeneity of hypertrophy in feline hypertrophic heart disease","volume":"7","author":"Peterson","year":"1993","journal-title":"J Vet Int Med"},{"key":"10.1016\/j.jvc.2015.10.006_bib9","first-page":"73","article-title":"Arterial thromboembolism in cats: acute crisis in 127 cases (1992\u20132001) and long-term management with low-dose aspirin in 24 cases","volume":"17","author":"Smith","year":"2003","journal-title":"J Vet Int Med"},{"issue":"S1","key":"10.1016\/j.jvc.2015.10.006_bib10","doi-asserted-by":"crossref","first-page":"S318","DOI":"10.1016\/j.jvc.2015.09.008","article-title":"Risk factors associated with sudden death versus congestive heart failure or arterial thromboembolism in cats with hypertrophic cardiomyopathy","volume":"17","author":"Payne","year":"2015","journal-title":"J Vet Cardiol"},{"key":"10.1016\/j.jvc.2015.10.006_bib11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/jfms.1999.0049","article-title":"Feline distal aortic thromboembolism: a review of 44 cases (1990\u20131998)","volume":"1","author":"Schoeman","year":"1999","journal-title":"J Feline Med Surg"},{"key":"10.1016\/j.jvc.2015.10.006_bib12","series-title":"Cardiovascular pathology","first-page":"471","article-title":"Interactions between heart and brain","author":"Vinters","year":"2001"},{"key":"10.1016\/j.jvc.2015.10.006_bib13","series-title":"The heart and stroke","first-page":"47","article-title":"Cardioembolic sources of stroke","author":"Salgado","year":"1987"},{"key":"10.1016\/j.jvc.2015.10.006_bib14","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0002-9149(81)90534-8","article-title":"The natural history of idiopathic dilated cardiomyopathy","volume":"47","author":"Fuster","year":"1981","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jvc.2015.10.006_bib15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/01.STR.15.2.282","article-title":"Cerebrovascular complications associated with idiopathic hypertrophic subaortic stenosis","volume":"15","author":"Furlan","year":"1984","journal-title":"Stroke"},{"issue":"S1","key":"10.1016\/j.jvc.2015.10.006_bib16","doi-asserted-by":"crossref","first-page":"S306","DOI":"10.1016\/j.jvc.2015.10.004","article-title":"Secondary prevention of cardiogenic embolism in the cat: the double-blind, randomized, positive-controlled Feline Arterial Thromboembolism; Clopidogrel vs. Aspirin Trial (FAT CAT)","volume":"17","author":"Hogan","year":"2015","journal-title":"J Vet Cardiol"},{"key":"10.1016\/j.jvc.2015.10.006_bib17","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/01.RES.39.5.736","article-title":"Inhibition of feline collateral vessel development following experimental thrombotic occlusion","volume":"39","author":"Schaub","year":"1976","journal-title":"Circ Res"},{"key":"10.1016\/j.jvc.2015.10.006_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1748-5827.1971.tb06212.x","article-title":"An investigation into the relationship of an aortic emboli to posterior paralysis in the cat","volume":"12","author":"Butler","year":"1971","journal-title":"J Small Anim Pract"},{"key":"10.1016\/j.jvc.2015.10.006_bib19","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/192979a0","article-title":"Production of aortic occlusion resembling acute aortic embolism syndrome in cats","volume":"192","author":"Imhoff","year":"1961","journal-title":"Nature"},{"key":"10.1016\/j.jvc.2015.10.006_bib20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1748-5827.1977.tb05878.x","article-title":"Five-hydroxytryptamine antagonists and feline aortic embolism","volume":"18","author":"Olmstead","year":"1977","journal-title":"J Small Anim Pract"},{"key":"10.1016\/j.jvc.2015.10.006_bib21","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.2460\/ajvr.1982.43.09.1647","article-title":"Effect of aspirin on collateral blood flow after experimental thrombosis of the feline aorta","volume":"43","author":"Schaub","year":"1982","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.jvc.2015.10.006_bib22","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1212\/01.WNL.0000061616.96745.90","article-title":"Collateral flow and ischemic brain lesions in patients with unilateral carotid artery occlusion","volume":"60","author":"Bisschops","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jvc.2015.10.006_bib23","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/01.STR.0000126043.83777.3a","article-title":"Regional angiographic grading system for collateral flow: correlation with cerebral infarction in patients with middle cerebral artery occlusion","volume":"35","author":"Kim","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.jvc.2015.10.006_bib24","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1161\/01.STR.24.11.1697","article-title":"Cerebellar infarction. Clinical and neuroimaging analysis in 293 patients. The Tohoku Cerebellar Infarction Study Group","volume":"24","author":"Tohgi","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.jvc.2015.10.006_bib25","first-page":"209","article-title":"Cardiogenic embolism of the upper extremity","volume":"23","author":"Haimovici","year":"1982","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.jvc.2015.10.006_bib26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/hrt.78.2.171","article-title":"Comparison of bronchopulmonary collaterals and collateral blood flow in patients with chronic thromboembolic and primary pulmonary hypertension","volume":"78","author":"Endys","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.jvc.2015.10.006_bib27","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0002-8703(83)90239-9","article-title":"The effects of aspirin and methysergide on responses to clot-induced pulmonary embolism","volume":"105","author":"Todd","year":"1983","journal-title":"Am Heart J"},{"key":"10.1016\/j.jvc.2015.10.006_bib28","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1113\/jphysiol.2002.023374","article-title":"Activated platelets contribute to stimulation of cardiac afferents during ischaemia in cats: role of 5-HT3 receptors","volume":"544","author":"Fu","year":"2002","journal-title":"J Physiol"},{"key":"10.1016\/j.jvc.2015.10.006_bib29","series-title":"Textbook of canine and feline cardiology: principles and clinical practice","first-page":"621","article-title":"Feline cardiomyopathies","author":"Fox","year":"1999"},{"key":"10.1016\/j.jvc.2015.10.006_bib30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.5326\/0410193","article-title":"Suspected iatrogenic paradoxical embolism in a cat","volume":"41","author":"Green","year":"2005","journal-title":"J Am Anim Hosp Assoc"},{"key":"10.1016\/j.jvc.2015.10.006_bib31","series-title":"Current veterinary therapy X","first-page":"295","article-title":"Therapy for feline aortic thromboembolism","author":"Pion","year":"1989"},{"key":"10.1016\/j.jvc.2015.10.006_bib32","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/jvim.12215","article-title":"Prognostic indicators in cats with hypertrophic cardiomyopathy","volume":"27","author":"Payne","year":"2013","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2015.10.006_bib33","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","article-title":"A common genetic variation in the 3\u02b9-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis","volume":"88","author":"Poort","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jvc.2015.10.006_bib34","first-page":"217","article-title":"Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management","volume":"34","author":"Dahlb\u00e4ck","year":"1997","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jvc.2015.10.006_bib35","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI110385","article-title":"Deficiency of protein C in congenital thrombotic disease","volume":"68","author":"Griffin","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jvc.2015.10.006_bib36","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-0038-1657551","article-title":"Protein S deficiency","volume":"78","author":"Borgel","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jvc.2015.10.006_bib37","first-page":"188","article-title":"Antithrombin III and its inherited deficiency states","volume":"34","author":"vanBoven","year":"1997","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jvc.2015.10.006_bib38","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1939-1676.2008.0098.x","article-title":"Hypercoagulability in cats with cardiomyopathy","volume":"22","author":"Stokol","year":"2008","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2015.10.006_bib39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1939-1676.1987.tb01982.x","article-title":"Platelet aggregation in feline cardiomyopathy","volume":"1","author":"Helenski","year":"1987","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2015.10.006_bib40","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2460\/ajvr.1994.55.05.619","article-title":"Platelet function and antithrombin, plasminogen, and fibrinolytic activities in cats with heart disease","volume":"55","author":"Welles","year":"1994","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.jvc.2015.10.006_bib41","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.theriogenology.2013.12.003","article-title":"Hemostatic profile during late pregnancy and early postpartum period in mares","volume":"81","author":"Bazzano","year":"2014","journal-title":"Theriogenology"},{"key":"10.1016\/j.jvc.2015.10.006_bib42","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1001\/archinte.159.22.2706","article-title":"Partial thromboplastin time: prediction of adverse events and poor prognosis by low abnormal values","volume":"159","author":"Reddy","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jvc.2015.10.006_bib43","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1476-4431.2011.00656.x","article-title":"Examination of hemostatic parameters to detect hypercoagulability in dogs with severe protein-losing nephropathy","volume":"21","author":"Donahue","year":"2011","journal-title":"J Vet Emerg Crit Care"},{"key":"10.1016\/j.jvc.2015.10.006_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/vec.12144","article-title":"Partnership on Rotational ViscoElastic Test Standardization (PROVETS): evidence-based guidelines on rotational viscoelastic assays in veterinary medicine","volume":"24","author":"Goggs","year":"2014","journal-title":"J Vet Emerg Crit Care"},{"key":"10.1016\/j.jvc.2015.10.006_bib45","series-title":"Current veterinary therapy XII","first-page":"868","article-title":"Warfarin therapy of the cat at risk of thromboembolism","author":"Harpster","year":"1995"},{"key":"10.1016\/j.jvc.2015.10.006_bib46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomized trials of antiplatelet therapy-I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","year":"1994","journal-title":"Br Med J"},{"key":"10.1016\/j.jvc.2015.10.006_bib47","first-page":"687","article-title":"Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: stroke prevention in atrial fibrillation II study","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jvc.2015.10.006_bib48","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/bmj.319.7215.958","article-title":"Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin","volume":"319","author":"Hellemons","year":"1999","journal-title":"Br Med J"},{"key":"10.1016\/j.jvc.2015.10.006_bib49","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/0140-6736(93)92358-Z","article-title":"Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European atrial fibrillation trial) study group","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jvc.2015.10.006_bib50","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(96)03487-3","article-title":"Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: stroke prevention in atrial fibrillation III randomised clinical trial","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jvc.2015.10.006_bib51","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.2460\/ajvr.1985.46.09.1820","article-title":"Effects of aspirin and propranolol on feline platelet aggregation","volume":"46","author":"Greene","year":"1985","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.jvc.2015.10.006_bib52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5326\/15473317-32-1-11","article-title":"Comparison of the effects of diltiazem and aspirin on platelet aggregation in cats","volume":"32","author":"Behrend","year":"1996","journal-title":"J Am Anim Hosp Assoc"},{"key":"10.1016\/j.jvc.2015.10.006_bib53","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0735-1097(97)00258-1","article-title":"Randomized trial of low molecular weight heparin (dalteparin) in prevention of left ventricular thrombus formation and arterial embolism after acute anterior myocardial infarction: the fragmin in acute myocardial infarction (FRAMI) study","volume":"30","author":"Kontny","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvc.2015.10.006_bib54","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1476-4431.2011.00681.x","article-title":"Lack of inhibitory effect of acetylsalicylic acid and meloxicam on whole blood platelet aggregation in cats","volume":"22","author":"Cathcart","year":"2012","journal-title":"J Vet Emerg Crit Care"},{"key":"10.1016\/j.jvc.2015.10.006_bib55","first-page":"168","article-title":"Clopidogrel: a new antiplatelet drug","volume":"2","author":"Lerner","year":"2000","journal-title":"Heart Dis"},{"key":"10.1016\/j.jvc.2015.10.006_bib56","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.103.3.363","article-title":"Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery","volume":"103","author":"Bhatt","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jvc.2015.10.006_bib57","first-page":"25","article-title":"Pharmacokinetics of clopidogrel","volume":"25","author":"Caplain","year":"1999","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jvc.2015.10.006_bib58","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00005344-200401000-00012","article-title":"In\u00a0vitro effects of clopidogrel on the platelet-subendothelium interaction, platelet thromboxane and endothelial prostacyclin production, and nitric oxide synthesis","volume":"43","author":"Arrebola","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jvc.2015.10.006_bib59","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0049-3848(98)00114-5","article-title":"Modulation of vasoconstriction by clopidogrel and ticlopidine","volume":"92","author":"Yang","year":"1998","journal-title":"Thromb Res"},{"key":"10.1016\/j.jvc.2015.10.006_bib60","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.0000072771.11429.83","article-title":"Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity","volume":"107","author":"Gurbel","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jvc.2015.10.006_bib61","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jacc.2006.11.044","article-title":"Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives","volume":"49","author":"Angiolillo","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvc.2015.10.006_bib62","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.amjcard.2003.10.042","article-title":"Frequency of nonresponse antiplatelet activity of clopidogrel during pre-treatment for cardiac catheterization","volume":"93","author":"Mobley","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jvc.2015.10.006_bib63","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1161\/01.ATV.0000223867.25324.1a","article-title":"Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel","volume":"26","author":"Angiolillo","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jvc.2015.10.006_bib64","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa0809171","article-title":"Cytochrome P-450 polymorphisms and response to clopidogrel","volume":"360","author":"Mega","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvc.2015.10.006_bib65","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1161\/01.CIR.0000130846.46168.03","article-title":"Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction","volume":"109","author":"Matetzky","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jvc.2015.10.006_bib66","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.jacc.2005.07.056","article-title":"Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST study","volume":"46","author":"Gurbel","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvc.2015.10.006_bib67","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.2460\/javma.2004.225.1406","article-title":"The pharmacodynamics and platelet responses to clopidogrel in cats","volume":"225","author":"Hogan","year":"2004","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.jvc.2015.10.006_bib68","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","article-title":"Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study","volume":"I","author":"Petersen","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.jvc.2015.10.006_bib69","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/01.CIR.84.2.527","article-title":"Stroke prevention in atrial fibrillation study. Final results","volume":"84","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.jvc.2015.10.006_bib70","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1056\/NEJM199011293232201","article-title":"The effect of low dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation","volume":"323","author":"The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvc.2015.10.006_bib71","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0735-1097(91)90585-W","article-title":"Canadian atrial fibrillation anticoagulation (CAFA) study","volume":"18","author":"Connolly","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvc.2015.10.006_bib72","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199211123272002","article-title":"Warfarin in the prevention of stroke associated with non-rheumatic atrial fibrillation","volume":"327","author":"Ezekowitz","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvc.2015.10.006_bib73","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1365-2885.2000.00269.x","article-title":"Plasma pharmacokinetics of warfarin enantiomers in cats","volume":"23","author":"Smith","year":"2000","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1016\/j.jvc.2015.10.006_bib74","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2885.2000.00268.x","article-title":"Pharmacodynamics of warfarin in cats","volume":"23","author":"Smith","year":"2000","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1016\/j.jvc.2015.10.006_bib75","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.2460\/javma.2005.226.1508","article-title":"Technique and outcome of mitral valve replacement in dogs","volume":"226","author":"Orton","year":"2005","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.jvc.2015.10.006_bib76","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1056\/NEJM199708143370710","article-title":"Heparin in acute coronary disease: requiem for a heavyweight?","volume":"337","author":"Armstrong","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvc.2015.10.006_bib77","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1378\/chest.126.3_suppl.188S","article-title":"Heparin and low-molecular-weight heparin: the seventh ACCP conference on antithrombotic and thrombolytic therapy","volume":"126","author":"Hirsh","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.jvc.2015.10.006_bib78","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0049-3848(02)00031-2","article-title":"Pharmacokinetics and pharmacodynamics of the prophylactic dose of enoxaparin once daily over 4 days in patients with renal impairment","volume":"105","author":"Sanderinka","year":"2002","journal-title":"Thromb Res"},{"key":"10.1016\/j.jvc.2015.10.006_bib79","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0140-6736(96)91270-2","article-title":"Fragmin during instability in coronary artery disease (FRISC) study group","volume":"347","author":"Low-molecular-weight heparin during instability in coronary artery disease","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jvc.2015.10.006_bib80","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.CIR.96.1.61","article-title":"Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC)","volume":"96","author":"Klein","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jvc.2015.10.006_bib81","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJM199708143370702","article-title":"A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and safety of subcutaneous enoxaparin in non-Q-wave coronary events study group","volume":"337","author":"Cohen","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvc.2015.10.006_bib82","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0140-6736(99)07350-X","article-title":"Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease. Investigators","volume":"354","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jvc.2015.10.006_bib83","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJM199709043371001","article-title":"Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. The Columbus investigators","volume":"337","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvc.2015.10.006_bib84","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJM199807093390204","article-title":"Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery","volume":"339","author":"Agnelli","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvc.2015.10.006_bib85","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199909093411103","article-title":"A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in medical patients with enoxaparin study group","volume":"341","author":"Samama","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvc.2015.10.006_bib86","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1001\/archinte.160.14.2199","article-title":"Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison. The North American fragmin trial investigators","volume":"160","author":"Hull","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jvc.2015.10.006_bib87","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1001\/archinte.160.14.2208","article-title":"Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin\/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American fragmin trial investigators","volume":"160","author":"Hull","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jvc.2015.10.006_bib88","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2460\/javma.2004.225.1237","article-title":"Use of low molecular weight heparin in cats: 57 cases (1999\u20132003)","volume":"225","author":"Smith","year":"2004","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.jvc.2015.10.006_bib89","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1939-1676.2007.tb02979.x","article-title":"Anticoagulant effects of low-molecular-weight heparins in healthy cats","volume":"21","author":"Alwood","year":"2007","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2015.10.006_bib90","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.2460\/ajvr.73.10.1577","article-title":"Viscoelastic pharmacodynamics after dalteparin administration to healthy dogs","volume":"73","author":"Brainard","year":"2012","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.jvc.2015.10.006_bib91","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0049-3848(91)90403-J","article-title":"Laboratory monitoring of the clinical effects of low molecular weight heparins","volume":"14","author":"Walenga","year":"1991","journal-title":"Thromb Res"},{"key":"10.1016\/j.jvc.2015.10.006_bib92","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.tvjl.2014.03.032","article-title":"Enoxaparin: pharmacokinetics and treatment schedule for cats","volume":"200","author":"Mischke","year":"2014","journal-title":"Vet J"},{"key":"10.1016\/j.jvc.2015.10.006_bib93","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1939-1676.2009.0412.x","article-title":"Antithrombotic effect of enoxaparin in clinically healthy cats: a venous stasis model","volume":"24","author":"Van De Wiele","year":"2010","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2015.10.006_bib94","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvc.2015.10.006_bib95","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvc.2015.10.006_bib96","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvc.2015.10.006_bib97","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2460\/ajvr.73.4.556","article-title":"Dose determination of fondaparinux in healthy cats","volume":"73","author":"Fiakpui","year":"2012","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.jvc.2015.10.006_bib98","article-title":"Pharmacokinetic and pharmacodynamic evaluation of oral rivaroxaban in healthy adult cats","author":"Dixon-Jimenez","year":"2015","journal-title":"J Vet Emerg Crit Care"}],"container-title":["Journal of Veterinary Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1760273415000971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1760273415000971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T04:29:18Z","timestamp":1748752158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1760273415000971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":98,"alternative-id":["S1760273415000971"],"URL":"https:\/\/doi.org\/10.1016\/j.jvc.2015.10.006","relation":{},"ISSN":["1760-2734"],"issn-type":[{"value":"1760-2734","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiogenic embolism in the cat","name":"articletitle","label":"Article Title"},{"value":"Journal of Veterinary Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvc.2015.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}